Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Entrada Therapeutics, Inc. | 2,963,066 | reported | 14 Nov 2025 | tx 1−200,000 |
| Cabaletta Bio, Inc. | 1,989,575 | reported | 07 Sept 2021 | tx 1−625,000 |
| Rallybio Corp | 1,335,637 | reported | 08 Feb 2022 | tx 2−210,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Nov 2025 | SALE | Entrada Therapeutics, Inc. | 200,000 | 8.80 USD | |
| 08 Feb 2022 | SALE | Rallybio Corp | 139,539 | 13.05 USD | |
| 08 Feb 2022 | SALE | Rallybio Corp | 70,461 | 13.05 USD | |
| 07 Sept 2021 | SALE | Cabaletta Bio, Inc. | 625,000 | 9.70 USD |